Keyword: Severin Schwan

Markets & Companies

Pharma Players Mostly Lift 2015 Guidance

07.10.2015 - After a challenging second quarter and first half 2015 – once again marked by foreign exchange turbulence and the impact of acquisitions and divestments – the international...

Markets & Companies

Drugs Industry Battered by Currency and Competition

13.03.2015 - Both European and US pharmaceutical industry players are highly research-oriented and possess very diversified portfolios. While each country has its national champions, Swiss...

News

Roche's $8 billion InterMune Buy Not a Sign of More Big Deals

19.09.2014 - The decision by Swiss drugmaker Roche in August to buy US biotech company InterMune for $8.3 billion was "exceptional" and not a sign of more ambitious plans for major acquisitions...

Strategy & Management

International Drugmakers Meet Challenges

08.05.2014 - In contrast to chemicals, the global pharmaceutical industry is little plagued by market cyclicality or general economic swings. But it faces equally daunting challenges, as the...

News

Roche Sees More Cancer Success as Sales Top Forecast

16.10.2012 - Swiss drugmaker Roche Holding is banking on a new generation of breast cancer medicines to drive sales growth after strong demand for its established cancer treatments helped it to...

News

Roche Q1 Sales Flat as Illumina Bid Battle Rages

12.04.2012 - Swiss drugmaker Roche dangled the prospect of a higher offer before reluctant U.S. bid target Illumina on Thursday along with broadly flat first-quarter sales supported by its top...

News

Roche's Strong Pipeline Leaves Shareholders Optimistic

02.03.2011 - Bruno Keller, a Roche shareholder for the past 10 years, is so confident about the Swiss drugmaker's prospects after a turbulent year that he is giving his wife Roche stock for her...

News

Severin Schwan of Roche Sees Generic Companies and Innovators As Winners

06.12.2010 - Roche Holding Chief Executive Severin Schwan believes the survivors in the pharmaceuticals sector will be large generic drugmakers, and companies who make innovative new products...